LinkedIn
ALOOSTA
Contact
Authorisations for the following chemical active substances have been extended (Commission Implementing Regulation (EU) 2020/869 of 24 June 2020 amending Implementing Regulation (EU) No 540/2011)
|
Active Ingredient |
Limited until |
Reference |
|
Famoxadon |
06/30/2021 |
https://eur-lex.europa.eu/eli/reg_impl/2020/869/oj
|
|
Flumioxazin |
||
|
Beflubutamid |
31.07.20121 |
|
|
Benalaxyl |
||
|
Benthiavalicarb |
||
|
Bifenazat |
||
|
Boscalid |
||
|
Bromoxynil |
||
|
Captan |
||
|
Cyazofamid |
||
|
Dimethomorph |
||
|
Ethephon |
||
|
Etoxazol |
||
|
Fenamiphos |
||
|
Fluoxastrobin |
||
|
Folpet |
||
|
Formetanat |
||
|
Metribuzin |
||
|
Milbemectin |
||
|
Phenmedipham |
||
|
Phosmet |
||
|
Pirimiphos-methyl |
||
|
Propamocarb |
||
|
Prothioconazo |
||
|
S-Metolachlor |
Author: Frank Mörsberger
Contact
Career